Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients
B Wirk, JR Wingard - Mycopathologia, 2009 - Springer
Invasive fungal infections (IFIs) pose the most serious infectious risk to patients with
hematologic malignancies and in those undergoing hematopoietic stem cell transplantation …
hematologic malignancies and in those undergoing hematopoietic stem cell transplantation …
[HTML][HTML] Antifungal prophylaxis in immunocompromised patients
L Vazquez - Mediterranean journal of hematology and infectious …, 2016 - ncbi.nlm.nih.gov
Invasive fungal infections (IFIs) represent significant complications in patients with
hematological malignancies. Chemoprevention of IFIs may be important in this setting, but …
hematological malignancies. Chemoprevention of IFIs may be important in this setting, but …
Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients
EJ Bow - Medical Mycology, 2005 - academic.oup.com
The risks for invasive fungal infections, particularly mould infections such as invasive
aspergillosis, among hematopoietic stem cell transplant (HSCT) recipients are linked to the …
aspergillosis, among hematopoietic stem cell transplant (HSCT) recipients are linked to the …
Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies
J Maertens - European journal of haematology, 2007 - Wiley Online Library
Objective: Patients with hematologic malignancies are at substantial risk of developing
invasive fungal infections (IFI) that are associated with substantial morbidity and mortality …
invasive fungal infections (IFI) that are associated with substantial morbidity and mortality …
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014
S Fleming, CK Yannakou, GM Haeusler… - Internal medicine …, 2014 - Wiley Online Library
There is a strong argument for the use of antifungal prophylaxis in high‐risk patients given
the significant mortality associated with invasive fungal disease, the late identification of …
the significant mortality associated with invasive fungal disease, the late identification of …
Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects
H Akan, VP Antia, M Kouba, J Sinko… - Journal of …, 2013 - academic.oup.com
Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …
morbidity and mortality in immunocompromised patients, especially those with …
Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies
S Murali, A Langston - Transplant Infectious Disease, 2009 - Wiley Online Library
Invasive fungal infection (IFI) is associated with significant morbidity and mortality in patients
with hematologic malignancies. There have been significant changes in the epidemiology …
with hematologic malignancies. There have been significant changes in the epidemiology …
Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy
OA Cornely, F Aversa, P Cook, B Jones… - European journal of …, 2011 - Wiley Online Library
Invasive fungal infection (IFI) is a persistent problem among critically ill and
immunocompromised patients, especially hematopoietic stem cell transplant or solid organ …
immunocompromised patients, especially hematopoietic stem cell transplant or solid organ …
Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients
NG Almyroudis, BH Segal - Expert Review of Anti-Infective Therapy, 2010 - Taylor & Francis
Patients with acute leukemia and hematopoietic stem cell transplant recipients are at risk of
a spectrum of invasive fungal diseases corresponding to the type and intensity of …
a spectrum of invasive fungal diseases corresponding to the type and intensity of …
Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts
D McCoy, DD DePestel… - … : The Journal of Human …, 2009 - Wiley Online Library
In recipients of hematopoietic stem cell transplants (HSCTs), the mortality associated with
invasive fungal infections (IFIs) remains high, despite the introduction of broad‐spectrum …
invasive fungal infections (IFIs) remains high, despite the introduction of broad‐spectrum …
相关搜索
- antifungal prophylaxis therapy in patients
- antifungal prophylaxis hematologic malignancies
- cell transplantation hematologic malignancy
- antifungal prophylaxis consensus guidelines
- antifungal prophylaxis immunocompromised patients
- prophylaxis in the management hematologic malignancy
- antifungal prophylaxis haematological malignancy
- antifungal prophylaxis empiric therapy